Orlando, FL -- (SBWIRE) -- 10/01/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Regeneron Pharmaceuticals Inc (NASDAQ:REGN), Penn Virginia Corporation (NYSE:PVA).
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) shares jumped 2.36% to $312.87. Research analysts at Oppenheimer boosted their price target on shares of REGN from $300.00 to $310.00 in a report released on Sept. 30. The firm currently has an “outperform” rating on the stock. Oppenheimer’s price objective would indicate a potential upside of 1.42% from the stock’s previous close.
Additionally, the company on Sept. 10 announced the appointment of Robert E. Landry as Senior Vice President, Finance. Mr. Landry will also assume the position of Chief Financial Officer of Regeneron on October 1. After 18 years as CFO, Murray A. Goldberg will transition to a new role as Senior Vice President, Administration in anticipation of his retirement at the end of 2014. Mr. Landry brings over two decades of varied financial and operating experience in the global pharmaceutical industry, most recently as Senior Vice President and Treasurer of Pfizer, Inc.
Are investors worried about the recent updates with REGN? Find out with a free trend analysis HERE
Penn Virginia Corporation (NYSE:PVA) shares gained 2.31% and closed at $6.65. The Board of Directors of Penn Virginia Corporation on Sept. 19 has declared a regular quarterly cash dividend of $150.00 per share on its 6.00 percent Series A convertible preferred stock. As a result, on October 15, 2013, a dividend of $1.50 per depositary share, each representing a 1/100 interest in a share of the Series A convertible preferred stock, will be paid to holders of record at the close of business on October 1, 2013.
Additionally, PVA’s stock had its price target increased by SunTrust from $8.00 to $9.00 in a research report sent to investors on Sept. 17. The firm currently has a buy rating on the stock.
Is PVA going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)